135 related articles for article (PubMed ID: 34315116)
1. A novel mechanism of lung cancer inhibition by methionine enkephalin through remodeling the immune status of the tumor microenvironment.
Zhang S; Huang H; Handley M; Griffin N; Bai X; Shan F
Int Immunopharmacol; 2021 Oct; 99():107999. PubMed ID: 34315116
[TBL] [Abstract][Full Text] [Related]
2. Regulatory role of methionine enkephalin in myeloid-derived suppressor cells and macrophages in human cutaneous squamous cell carcinoma.
Bai X; Shan F; Qu N; Huang H; Handley M; Griffin N; Zhang S; Cao X
Int Immunopharmacol; 2021 Oct; 99():107996. PubMed ID: 34311187
[TBL] [Abstract][Full Text] [Related]
3. Methionine enkephalin inhibits colorectal cancer by remodeling the immune status of the tumor microenvironment.
Wang X; Li S; Yan S; Shan Y; Wang X; Jingbo Z; Wang Y; Shan F; Griffin N; Sun X
Int Immunopharmacol; 2022 Oct; 111():109125. PubMed ID: 35988519
[TBL] [Abstract][Full Text] [Related]
4. Methionine enkephalin suppresses lung cancer metastasis by regulating the polarization of tumor-associated macrophages and the distribution of myeloid-derived suppressor cells in the tumor microenvironment and inhibiting epithelial-mesenchymal transition.
Zhang S; Geng J; Shan F; Shan Y; Griffin N; Wu B; Wang X
Int Immunopharmacol; 2023 May; 118():110064. PubMed ID: 36989897
[TBL] [Abstract][Full Text] [Related]
5. Methionine enkephalin, its role in immunoregulation and cancer therapy.
Zhao D; Plotnikoff N; Griffin N; Song T; Shan F
Int Immunopharmacol; 2016 Aug; 37():59-64. PubMed ID: 26927200
[TBL] [Abstract][Full Text] [Related]
6. Methionine enkephalin (MENK) suppresses lung cancer by regulating the Bcl-2/Bax/caspase-3 signaling pathway and enhancing natural killer cell-driven tumor immunity.
Zhang S; Liu N; Ma M; Huang H; Handley M; Bai X; Shan F
Int Immunopharmacol; 2021 Sep; 98():107837. PubMed ID: 34116288
[TBL] [Abstract][Full Text] [Related]
7. Methionine enkephalin (MENK) mounts antitumor effect via regulating dendritic cells (DCs).
Meng Y; Gao X; Chen W; Plotnikoff NP; Griffin N; Zhang G; Shan F
Int Immunopharmacol; 2017 Mar; 44():61-71. PubMed ID: 28088065
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo killing effects of methionine enkephalin on osteosarcoma.
Huang H; Wang X; Zhang S; Bai X; Griffin N; Shan Y; Shan F
Int Immunopharmacol; 2023 Dec; 125(Pt B):111226. PubMed ID: 37976597
[TBL] [Abstract][Full Text] [Related]
9. Induction on differentiation and modulation of bone marrow progenitor of dendritic cell by methionine enkephalin (MENK).
Liu J; Chen W; Meng J; Lu C; Wang E; Shan F
Cancer Immunol Immunother; 2012 Oct; 61(10):1699-711. PubMed ID: 22392190
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK).
Li W; Chen W; Herberman RB; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
Cancer Lett; 2014 Mar; 344(2):212-22. PubMed ID: 24291668
[TBL] [Abstract][Full Text] [Related]
11. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.
Li X; Meng Y; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
Cancer Biol Ther; 2015; 16(3):450-9. PubMed ID: 25701137
[TBL] [Abstract][Full Text] [Related]
12. Functional modulation of the pathway between dendritic cells (DCs) and CD4+T cells by the neuropeptide: methionine enkephalin (MENK).
Shan F; Xia Y; Wang N; Meng J; Lu C; Meng Y; Plotnikoff NP
Peptides; 2011 May; 32(5):929-37. PubMed ID: 21335041
[TBL] [Abstract][Full Text] [Related]
13. Killing effect of methionine enkephalin on melanoma in vivo and in vitro.
Wang DM; Jiao X; Plotnikoff NP; Griffin N; Qi RQ; Gao XH; Shan FP
Oncol Rep; 2017 Oct; 38(4):2132-2140. PubMed ID: 28849104
[TBL] [Abstract][Full Text] [Related]
14. Methionine enkephalin (MENK) inhibits human gastric cancer through regulating tumor associated macrophages (TAMs) and PI3K/AKT/mTOR signaling pathway inside cancer cells.
Wang X; Jiao X; Meng Y; Chen H; Griffin N; Gao X; Shan F
Int Immunopharmacol; 2018 Dec; 65():312-322. PubMed ID: 30343258
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory and metabolic reprogramming effects of MENK produce antitumor response in CT26 tumor-bearing mice.
Tuo Y; Zhang Z; Tian C; Hu Q; Xie R; Yang J; Zhou H; Lu L; Xiang M
J Leukoc Biol; 2020 Jul; 108(1):215-228. PubMed ID: 31994797
[TBL] [Abstract][Full Text] [Related]
16. Methionine enkephalin inhibited cervical cancer migration as well as invasion and activated CD11b
Qu N; Meng Y; Zhai J; Griffin N; Shan Y; Gao Y; Shan F
Int Immunopharmacol; 2023 Nov; 124(Pt B):110967. PubMed ID: 37741126
[TBL] [Abstract][Full Text] [Related]
17. Novel modulation on myeloid-derived suppressor cells (MDSCs) by methionine encephalin (MENK).
Geng J; Yuan Y; Jiao X; Wang R; Liu N; Chen H; Griffin N; Shan F
Int Immunopharmacol; 2019 Mar; 68():193-203. PubMed ID: 30654309
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the growth of human melanoma cells by methionine enkephalin.
Wang DM; Wang GC; Yang J; Plotnikoff NP; Griffin N; Han YM; Qi RQ; Gao XH; Shan FP
Mol Med Rep; 2016 Dec; 14(6):5521-5527. PubMed ID: 27878237
[TBL] [Abstract][Full Text] [Related]
19. Methionine enkephalin (MENK) regulates the immune pathogenesis of type 2 diabetes mellitus via the IL-33/ST2 pathway.
Zhang K; Yang J; Ao N; Jin S; Qi R; Shan F; Du J
Int Immunopharmacol; 2019 Aug; 73():23-40. PubMed ID: 31078923
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of methionine encephalin (MENK) combined with pidotimod(PTD) on the maturation of murine dendritic cells (DCs).
Meng Y; Wang Q; Zhang Z; Wang E; Plotnikoff NP; Shan F
Hum Vaccin Immunother; 2013 Apr; 9(4):773-83. PubMed ID: 23470544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
